CTOs on the Move

OnKure Therapeutics

www.onkuretherapeutics.com

 
OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure`s drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenvironment such that checkpoint inhibition is optimized.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

OnKure Therapeutics raised $55M on 03/04/2021

Similar Companies

Champions Oncology

Champions Oncology is a company that develops technology solutions and services for personalizing the development and use of oncology drugs. Their technology-enabled research platforms empower biopharma to create a comprehensive understanding of tumor ...

Brains Bioceutical

Brains Bioceutical Corp is a globally recognized leader in GMP-certified production of naturally-sourced Active Pharmaceutical Ingredients (API).

Kyowa Kirin

Kyowa Kirin Co., Ltd.

Protemix

Protemix is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Airway Therapeutics

Airway Therapeutics is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.